BE901095A - Nouvelles compositions anthelminthiques et leur preparation. - Google Patents

Nouvelles compositions anthelminthiques et leur preparation.

Info

Publication number
BE901095A
BE901095A BE0/214033A BE214033A BE901095A BE 901095 A BE901095 A BE 901095A BE 0/214033 A BE0/214033 A BE 0/214033A BE 214033 A BE214033 A BE 214033A BE 901095 A BE901095 A BE 901095A
Authority
BE
Belgium
Prior art keywords
novel
preparation
anthelminthic compositions
anthelminthic
compositions
Prior art date
Application number
BE0/214033A
Other languages
English (en)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of BE901095A publication Critical patent/BE901095A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Une composition pharmaceutique qui comprend le sel de nitroxynil de lévamisole en solution dans un solvant comprenant du diméthylisosorbide, du glycofurol ou un mélange des deux et contenant jusqu'à 40 % (poids/volume) de sel de nitroxynil de lévamisole. Cette composition possède des propriétés anthelminthiques et est utilisée dans la lutte contre l'helminthiose. Par ailleurs, elle se présente sous la forme d'un dosage unitaire et est destinée à une administration parentérale.
BE0/214033A 1983-11-21 1984-11-20 Nouvelles compositions anthelminthiques et leur preparation. BE901095A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331037A GB8331037D0 (en) 1983-11-21 1983-11-21 Compositions of matter

Publications (1)

Publication Number Publication Date
BE901095A true BE901095A (fr) 1985-05-20

Family

ID=10552109

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214033A BE901095A (fr) 1983-11-21 1984-11-20 Nouvelles compositions anthelminthiques et leur preparation.

Country Status (15)

Country Link
JP (1) JPS60123419A (fr)
AU (1) AU3564984A (fr)
BE (1) BE901095A (fr)
CA (1) CA1236402A (fr)
CH (1) CH662273A5 (fr)
DE (1) DE3442402A1 (fr)
DK (1) DK548884A (fr)
ES (1) ES537825A0 (fr)
FR (1) FR2555047B1 (fr)
GB (2) GB8331037D0 (fr)
HU (1) HU196307B (fr)
IT (1) IT1177262B (fr)
NL (1) NL8403528A (fr)
NZ (1) NZ210247A (fr)
ZA (1) ZA849008B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147883A3 (fr) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Formulations "pour-on" anthelmintiques aqueuses et non-aggressives
EP0202568A1 (fr) * 1985-05-13 1986-11-26 Syntex (U.S.A.) Inc. Compositions anthelminthiques
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
CN100500648C (zh) * 2006-12-29 2009-06-17 浙江工业大学 一种硝碘酚腈的合成方法
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais
NZ611474A (en) * 2010-12-27 2015-08-28 Intervet Int Bv Topical localized isoxazoline formulation comprising glycofurol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
DE3163536D1 (en) * 1980-11-20 1984-06-14 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions

Also Published As

Publication number Publication date
GB8331037D0 (en) 1983-12-29
HUT35955A (en) 1985-08-28
FR2555047B1 (fr) 1987-04-17
IT8423660A0 (it) 1984-11-20
JPS60123419A (ja) 1985-07-02
ES8600933A1 (es) 1985-10-16
AU3564984A (en) 1985-05-30
HU196307B (en) 1988-11-28
NL8403528A (nl) 1985-06-17
FR2555047A1 (fr) 1985-05-24
CA1236402A (fr) 1988-05-10
ZA849008B (en) 1985-07-31
DK548884D0 (da) 1984-11-19
IT8423660A1 (it) 1986-05-20
GB2150024A (en) 1985-06-26
IT1177262B (it) 1987-08-26
DE3442402A1 (de) 1985-05-30
GB8429264D0 (en) 1984-12-27
GB2150024B (en) 1987-02-04
NZ210247A (en) 1988-01-08
ES537825A0 (es) 1985-10-16
CH662273A5 (fr) 1987-09-30
DK548884A (da) 1985-05-22

Similar Documents

Publication Publication Date Title
Veber et al. A super active cyclic hexapeptide analog of somatostatin
IL71326A (en) Corticotropin releasing factor analogs and pharmaceutical compositions containing them
EP0327756B1 (fr) Compositions pharmaceutiques contenant une calcitonine et un glycyrrhizinate comme promoteur d'absoption
EP0221041A3 (fr) Dérivés de benzimidazole, leur préparation et leur application comme médicaments
DE3065420D1 (en) Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours
TNSN03085A1 (fr) Composition parenterale reconstituable contenant un inhibiteur de cox-2
IL93119A0 (en) Purified intracellular adhesion molecule-1,dna encoding it,its preparation and pharmaceutical compositions containing it
BE904233A (fr) Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant.
BE901095A (fr) Nouvelles compositions anthelminthiques et leur preparation.
BE904796A (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant.
US5491171A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
EP0173664A3 (fr) Dérivés de benzimidazole biologiquement actifs et leur procédé de préparation
AU599034B2 (en) Furosemide salts
CA2318326A1 (fr) Nouveaux pentasaccharides, procedes de preparation et compositions pharmaceutiques ainsi constituees
KR920008060A (ko) 약제적 활성물질을 제피 또는 봉매하기 위한 갈락토만난 유도체
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
US3657436A (en) Method of treating col-sk virus infections
PT84943B (pt) Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de pelo menos, um polipeptido, um monossacarido e um polioxialquileno-eter
EP0500586A1 (fr) Inhibiteurs de biosynthese de pyrimidine utiles en tant qu'agents immunosuppresseurs
JP3535207B2 (ja) 抗ガン剤及びｇｒｐレセプター拮抗剤
IE44117B1 (en) Pharmaceutical compositions having diuretic and antihypertensive activity
US3466377A (en) Aralkyl aliphatic sulfoxide oral,parenteral and rectal dosage units for pain,fever and inflammation
CA2167841A1 (fr) Methode d'inhibition de la production de virus d'immunodeficience humaine a l'aide de derives de substitution d'azaspiranes
US3502774A (en) Anthelmintic method using 6-methoxy-1-phenazinol 5,10-dioxide
US3704244A (en) N-lower alkyl-substituted n'-(beta-(2',5'-diphenylpyrolyl - 1')) ethylhomopiperazines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MAY & BAKER LTD

Effective date: 19891130